- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients with WHIM Syndrome with Open-Label Extension
This study looks at a new medicine called Mavorixafor for people with WHIM syndrome. It compares the medicine to a dummy pill to see if it helps improve the body's infection-fighting cells and reduce warts and infections. It also checks how safe the medicine is.
For: WHIM SyndromeSpain · France · Italy - RecruitingPHASE3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
This study looks at a new medicine called Mavorixafor for people with a blood condition called neutropenia. It aims to see if the drug can help reduce infections and increase white blood cells called neutrophils, which fight infections.
For: NeutropeniaUnited States · Argentina · Australia